BDTX — Black Diamond Therapeutics Share News
0.000.00%
Last trade - 00:00- $100.28m
- -$17.98m
- $70.00m
Black Diamond Therapeutics announces CEO change; stock falls
Brief: Black Diamond Therapeutics Announces CEO Transition
Brief: Black Diamond Therapeutics -First Patients Dosed In Phase 1 Clinical Trial Expansion Cohorts Evaluating Bdtx-1535
Black Diamond Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Black Diamond Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Refinitiv Newscasts - U.S. Week Ahead: Wall St rallies as inflation cools and Apple hits $3 trillion in market cap
U.S. STOCKS ON THE MOVE-US banks, Circor
U.S. STOCKS ON THE MOVE-Bausch + Lomb, Apple Inc, Madrigal Pharma
U.S. STOCKS ON THE MOVE-Bright Health, Baudax Bio
U.S. STOCKS ON THE MOVE-Aurinia Pharma, Black Diamond Therapeutics, Nvidia
Black Diamond Therapeutics jumps after $75 mln equity raise, analyst upgrade
Black Diamond Therapeutics rises after pricing $75 mln stock offering
Brief: Black Diamond Therapeutics Announces Pricing Of Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx
U.S. STOCKS ON THE MOVE-Virgin Galactic, Occidental Petroleum, Joby Aviation
Black Diamond Therapeutics drops after $75 mln stock offering
Brief: Black Diamond Therapeutics Announces Proposed Public Offering Of Common Stock
U.S. RESEARCH ROUNDUP-Eli Lilly, Regeneron Pharmaceuticals, Synopsys